Concepedia
Statistics
Publications
4
Citations
139
H-Index
Active since
2014
Affiliations
Samsung Medical Center(Current)
Sungkyunkwan University
Samsung (South Korea)
Yeon-Hee Bae is an author at Samsung Medical Center specializing in oncology, molecular oncology, and cancer pharmacology.
Publications per year
2014–2017
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma
Bo Mi Ku, Seong Yoon Yi, Jiae Koh et al. · Oncotarget · 2016 · 56 citations · Full text
Medicine, Oncology, Pharmacology +16
Mutational status of <i>TP53</i> defines the efficacy of Wee1 inhibitor AZD1775 in <i>KRAS</i>-mutant non-small cell lung cancer
Bo Mi Ku, Yeon-Hee Bae, Jiae Koh et al. · Oncotarget · 2017 · 40 citations · Full text
Medicine, Molecular Biology, Oncology +15
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer
Bo Mi Ku, Eun Hye Jho, Yeon-Hee Bae et al. · Investigational New Drugs · 2014 · 26 citations
Medicine, Oncology, Pharmacology +15
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFRL858R/T790M in non-small cell lung cancer cells
Bo Mi Ku, Yeon-Hee Bae, Jiae Koh et al. · Investigational New Drugs · 2016 · 17 citations
Medicine, Molecular Biology, Oncology +9
1–4 of 4